Hervé Girsault
Venture Partner @ Inventages Venture Capital Investment Inc.
Kloten, Switzerland
Hervé Girsault is a startup investor at Inventages Venture Capital Investment Inc. in Kloten. Hervé has more than15 years of accomplishments in the medical food, consumer health, pharmaceuticals and biotech sectors, primarily as Global Head of Business Development and Mergers & Acquisitions for several leading international corporations. He was also the CEO of several companies in the US and in Europe and was the co-founder of biotechcompanies in Switzerland.Hervé is the founder and managing partner of CHG Biotech Venture a M&A and Business Development advisory firm focused on HealthCare and Health Nutrition. His professional experience includes senior management positions at Novartis, CCBR-Synarc and Gerber. He holds a BA majoring in Economics & Commerce and a MBA from Columbia University. Hervé is a member of the board of directors of several companies.
Last updated:
For AI agents: llms.txt
About Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals,enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.
Inventages Venture Capital Investment Inc. Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ashok Dhanrajgir
Senior Vice President
|
|||
|
Hervé Girsault
Venture Partner
|
|||
Bill Kermode
Partner
|
|||
Erich Sieber
Senior Vice President
|
|||
François Struye de Swielande
Senior Vice President
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
